4/ Blockbusters treated 15 therapeutic areas in 2023. Oncology (26%), cardiometabolic (15%), and autoimmune (11%) had the most -- over half of all blockbusters. There was also one blockbuster drug for dogs. #barkbark

5/ Blockbuster drugs were equally likely to be a biologic or small molecule in 2023. However, the top 20 (70%), top 50 (56%), and autoimmune therapies (82%) were more likely to be biologics. Oncology (43%) and cardiometabolic (35%) drugs less likely to be biologics.